Security key
74366E102
Protagonist Therapeutics, Inc - COMMON STOCK (PTGX)
CUSIP: 74366E102
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 59,715,204
- Total 13F value
- $1,727,559,912
- Share change
- +2,283,790
- Put/Call ratio
- 203%
- SEC-reported price per share
- $28.93
- Number of holders
- 183
- Value change
- +$80,356,864
- Number of buys
- 109
- Number of sells
- 74
- Shares outstanding
- 63,608,245
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
183
Top holders
10
PTGX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Protagonist Therapeutics, Inc SEC filings
Protagonist Therapeutics, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74366E102
Recent filing periods:
Ownership snapshot
Top reported holders of PTGX - Protagonist Therapeutics, Inc - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 9%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
9%
FARALLON CAPITAL MANAGEMENT LLC
9%
BlackRock Finance, Inc.
8.7%
RTW INVESTMENTS, LP
8.4%
VANGUARD GROUP INC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
9%
|
$131,729,365
5,744,848 shares
|
— | 31 Dec 2023 |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
Company
|
9%
|
$131,490,480
5,734,430 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
8.7%
|
$127,121,672
5,543,902 shares
|
— | 31 Dec 2023 |
| RTW INVESTMENTS, LP |
13F
Company
|
8.4%
|
$121,884,736
5,315,514 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
5%
|
$72,319,294
3,153,916 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
4.3%
|
$62,597,272
2,729,929 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
183
Shares
59,715,204
Rows available
183
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
155
Q1 2024 holders
183
Holder diff
28
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend